Drug | Clinical trial | Disease | Clinical trial identifier | Study start date |
---|---|---|---|---|
Brequinar | Phase I/II | Acute myeloid leukemia | NCT03760666 | November 26, 2018 |
Leflunomide | Phase I/II | Multiple myeloma | NCT02509052 | November 2, 2015 |
Teriflunomide | Phase IV | Multiple sclerosis | NCT01970410 | October 2013 |
ASLAN003 | Phase II | Acute myeloid leukemia | NCT03451084 | January 5, 2018 |
BAY2402234 | Phase I | Leukemia | NCT03404726 | March 29, 2018 |
IMU-838 | Phase II | Ulcerative colitis | NCT03341962 | March 15, 2018 |
PTC299 | Phase I | Acute myeloid leukemia | NCT03761069 | October 29,2018 |